Journals / Dicle Tıp Dergisi / 2016 / Cilt: 43 - Sayı: 2

Diabetes Mellitus and Epigenetic Mechanisms

Diabetes Mellitus ve Epigenetik Mekanizmalar

Pages
375–382
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we will summarize the relationship of DM and its complications with DNA and RNA methylation, which are among the most important modifications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetes Mellitus (DM) is an important disease caused by insulin deficiency or insulin receptor resistance and characterized by hyperglycemia.
📊
Key Findings & Data:The prevalence rate of DM is increasing rapidly worldwide and its associated complications affect the quality of life of patients adversely.
💡
Conclusion & Impact:In this review, we will summarize the relationship of DM and its complications with DNA and RNA methylation, which are among the most important modifications.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diabetes Mellitus (DM) is an important disease caused by insulin deficiency or insulin receptor resistance and characterized by hyperglycemia. The prevalence rate of DM is increasing rapidly worldwide and its associated complications affect the quality of life of patients adversely. In addition, high medical costs for its treatment bring significant economic load on countries. Epigenetics is the reversible modifications on the genome, which lead to changes in gene expression without any alteration in the DNA sequence. Epigenetic modifications can easily be affected by environmental factors and abnormalities in these modifications have been linked to many diseases including cancer and neurodegenerative disorders. In this review, we will summarize the relationship of DM and its complications with DNA and RNA methylation, which are among the most important modifications.

Özet

Diabetes Mellitus (DM), insülin eksikliği veya insülin reseptör direnci kaynaklı ve hiperglisemi ile karakterize önemli bir metabolik bozukluktur. Dünya çapında görülme sıklığı giderek artmakta olan DM, sebep olduğu komplikasyonlar ile yaşam kalitesini olumsuz etkilemektedir. Bunun yanında yüksek tedavi maliyetleriyle ülkelere ciddi ekonomik yükler getirmektedir. Epigenetik, geri dönüşümlü çeşitli modifikasyonlar sayesinde DNA dizisi değişmeden gen ifadesinin değişikliğe uğramasını ifade eder. Çevresel faktörlerden kolaylıkla etkilenebilen bu epigenetik modifikasyonlardaki anormal değişimler başta kanser ve nörodejeneratif bozukluklar olmak üzere birçok hastalıkla ilişkilendirilmiştir. Bu derlemede, epigenetik modifikasyonların en önemlilerinden olan DNA ve RNA metilasyonunun DM ve komplikasyonları ile ilişkisi özetlenecektir.

🔖

Cite This Article

ESER, B. E., YAZGAN, Ü. C., GÜRSES, S. A., AYDIN, M. (2016). Diabetes Mellitus and Epigenetic Mechanisms. Dicle Tıp Dergisi, Cilt: 43 - Sayı: 2, 375–382. https://ajindex.com/articles/204902

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. International Diabetes Federation: IDF Diabetes Atlas. Brussels, Belgium 2013. Ulaşılabileceği adres: https://www.idf. org/sites/default/files/EN_6E_Atlas_Full_0.pdf 2. Satman I, ve TURDEP-II çalışma grubu. TURDEP-II Sonuç- larıç Türk Endokronoloji ve Metabolizma Derneği Resmi Web Sayfası 2011
  2. Ulaşılabileceği adres: http://www.turkendokrin.org/files/file/TURDEP_ II_2011.pdf 3. Tanrıverdi MH, Çelepkolu T, Aslanhan H. Diabetes mellitus and primary healthcare. J Clin Exp Invest 2013
  3. Yazgan ÜC, Taşdemir E, Bilgin HM, et al. Comparison of the anti-diabetic effects of resveratrol, gliclazide and losartan in streptozotocin-induced experimental diabetes. Arch Physiol Biochem 2015
  4. Şahpaz F, Ulutaş KT. Assessment of mean platelet volume in type 2 diabetics receiving insulin or oral antidiabetic agents. Dicle Med J 2015
  5. Yenigün EC, Okyay GU, Pirpir A, et al. Increased mean platelet volume in type 2 diabetes mellitus. Dicle Med J 2014
  6. Portela A, Esteller M. Epigenetic modifications and human disease. Nat biotechnol 2010
  7. Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat Rev Genet 2014
  8. Wu H, Zhang Y. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 2014
  9. Liu N, Pan T. RNA epigenetics. Transl Res 2015
  10. İzmirli M, Tufan T, Alptekin D. DNA metilasyonu. Arşiv Kaynak Tarama Dergisi 2012
  11. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006
  12. Shen L, Song CX, He C, Zhang Y. Mechanism and function of oxidative reversal of DNA and RNA methylation. Annu Rev Biochem 2014
  13. Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009
  14. Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 2013
  15. Piccolo FM, Fisher AG. Getting rid of DNA methylation. Trends Cell Biol 2014
  16. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007
  17. Akhavan-Niaki H, Samadani AA. DNA methylation and cancer development: molecular mechanism. Cell Biochem Biophys 2013
  18. Yang M, Park JY. DNA methylation in promoter region as biomarkers in prostate cancer. Methods Mol Biol 2012
  19. Scourzic L, Mouly E, Bernard